Abstract Human synovial mesenchymal stem cells (hSMSCs) are a promising cell source for cartilage regeneration because of their superior chondrogenic potential in vitro. This study aimed to further optimize the conditions for inducing chondrogenesis of hSMSCs, focusing on the dose of dexamethasone in combination with transforming growth factor-b3 (TGFb3) and/or bone morphogenetic protein-2 (BMP2). When hSMSCs-derived aggregates were cultured with TGFb3, dexamethasone up to 10 nM promoted chondrogenesis, but attenuated it with heterogeneous tissue formation when used at concentrations over than 100 nM. On the other hands, BMP2-induced chondrogenesis was remarkably disturbed in the presence of more than 10 nM dexamethasone along with unexpected adipogenic differentiation. In the presence of both TGFb3 and BMP2, dexamethasone dose dependently promoted cartilaginous tissue formation as judged by tissue volume, proteoglycan content, and type 2 collagen expression, whereas few adipocytes were detected in the formed tissue when cultures were supplemented with over 100 nM dexamethasone. Even in chondrogenic conditions, dexamethasone thus affected hSMSCs differentiation not only toward chondrocytes, but also towards adipocytes dependent on the dose and combined growth factor. These findings have important implications regarding the use of glucocorticoids in in vitro tissue engineering for cartilage regeneration using hSMSCs.
Introduction
Chondral injury does not usually heal spontaneously. Thus, implantation of autologous cartilage or chondrocyte-derived tissue has been conducted to repair Electronic supplementary material The online version of this article (https://doi.org/10.1007/s10616-018-0191-y) contains supplementary material, which is available to authorized users.
cartilage in clinical setting. However, these methods present limitations such as donor site morbidity and limited availability of chondrocytes, which have not been resolved (Huey et al. 2012) . Therefore, engineering cartilaginous implants from other cell sources is promising for the future of cartilage regeneration.
To this end, mesenchymal stem cells (MSCs) have been expected as a promising cell source because they can be harvested with minimally invasive procedures and present proliferative and chondrogenic capacities (Huey et al. 2012) . Many studies investigated the optimum conditions for induction of chondrogenic differentiation of MSCs (Inui et al. 2012) . In most studies, dexamethasone is traditionally used with growth factors to drive the differentiation of MSCs toward chondrogenesis (Fellows et al. 2016) . Dexamethasone is a synthetic glucocorticoid which binds to homometric glucocorticoid receptor, thereby affecting cell viability and differentiation of various cell types in vitro. In general, dexamethasone is commonly used for the differentiation of stem cells into several lineages, not only chondrocytes but also osteoblasts, adipocytes, and others (Dimarino et al. 2013) .
To drive the differentiation of MSCs toward chondrogenesis, growth factors such as transforming growth factor-bs (TGFbs) and bone morphogenetic proteins (BMPs) have been often used. The synergistic effect of dexamethasone and TGFbs is well known (Bilgen et al. 2007; Derfoul et al. 2006; Hara et al. 2015; Johnstone et al. 1998 ). However, results vary among reports; some studies showed a drastic effect (Bilgen et al. 2007; Johnstone et al. 1998) , while others showed only a marginal effect (Derfoul et al. 2006; Hara et al. 2015) . Furthermore, the effect of the combination of dexamethasone with BMPs is conflicting among reports (Diekman et al. 2010; Park et al. 2005; Shintani and Hunziker 2011) . Of note, dexamethasone is used in re-differentiation of dedifferentiated chondrocytes and stimulates the synthesis of cartilaginous matrices (Ahmed et al. 2014) , while in a pre-chondrogenic cell line, dexamethasone inhibits chondrogenesis (Fujita et al. 2004; Naito et al. 2015) . Altogether, these data suggest that the effect of dexamethasone on chondrogenesis may differ depending on the cell type (Randau et al. 2013; Shintani and Hunziker 2011) , combined growth factors Hunziker 2007, 2011) , and culture systems (Florine et al. 2013; Medrado et al. 2006; Park et al. 2005) . Taken together, cell specific experiments will be required to apply dexamethasone on the induction of chondrogenesis from MSCs.
Among MSCs, synovial derived MSCs (SMSCs) have been expected as an attractive cell source for the engineering of cartilage. Several reports demonstrated that SMSCs have the greatest chondrogenic potential in vitro compared with MSCs derived from other tissues (Koga et al. 2008; Yoshimura et al. 2007 ). We also previously reported the successful formation of a cartilaginous implant from human SMSCs (hSMSCs) Yasui et al. 2016) . In our previous studies, only BMP2 was applied to induce chondrogenesis, but another group reported that the combination of TGFb3, BMP2, and dexamethasone was the best condition to induce chondrogenesis and form cartilaginous tissue from hSMSCs (Shirasawa et al. 2006) . Thus, the combination and the concentration of growth factors have often been examined for chondrogenic induction of MSCs (Awad et al. 2003; Inui et al. 2012; Lee et al. 2009; Sekiya et al. 2001; Shintani and Hunziker 2011; Shirasawa et al. 2006 ), while dexamethasone is routinely used at the concentration of 100 nM in chondrogenic medium in most previous reports (Ahmed et al. 2014; Bilgen et al. 2007; Derfoul et al. 2006; Diekman et al. 2010; Florine et al. 2013; Hara et al. 2015; Johnstone et al. 1998; Koga et al. 2008; Park et al. 2005; Randau et al. 2013; Hunziker 2007, 2011; Shirasawa et al. 2006; Yoshimura et al. 2007 ). However, it is possible that dexamethasone concentration sensitively affects the chondrogenic differentiation of hSMSCs as shown in other cell types (Awad et al. 2003; Fujita et al. 2004; Tangtrongsup and Kisiday 2016) . To further optimize the efficient conditions for chondrogenic induction and cartilage tissue formation from hSMSCs, we here investigated the influence of the dose of dexamethasone on TGFb3-and/or BMP2-induced chondrogenesis and cartilaginous tissue formation from hSMSCs for the first time.
Materials and methods
Isolation and culture of human synovial MSCs (hSMSCs) Adult human synovium (n = 3: donor 1; male, age 30, donor 2; male, age 18, donor 3; female, age 38) were obtained at the time of arthroscopic surgery of the anterior crucial ligament reconstruction in accordance with a protocol approved by the Institutional Ethics Committee. For isolation of synovial MSCs, specimens were minced and digested with 0.25% trypsin/ EDTA (Gibco, Carlsbad, CA, USA) for 30 min, and then floating adipose tissues were removed after centrifugation to obtain high chondrogenic potential cells (Katagiri et al. 2017; Mochizuki et al. 2006) . Non-floating tissues were resuspended in DMEM (Gibco) containing 10%FBS (Sigma-Aldrich, St Louis, MO, USA) and supplemented with 400 unit/ mL collagenase type A (Worthington, Lakewood, NJ, USA) and incubated at 37°C. After 3 h, dissociated cells were collected, washed by centrifugation, and then cultured with high glucose-DMEM containing 10% FBS and 1% antibiotic-antimitotic (SigmaAldrich) (GM: growth medium) at 37°C with humidified 5% CO 2 . hSMSCs were expanded as previously described Yasui et al. 2016 ) and used for experiments at passage 3 or 4.
The cells have been already characterized with FACS analysis and surface antigen profile was as follows: CD34 (-), CD45 (-), CD44 (?), CD73 (?), CD90 (?), CD105 (?). The results were consistent with a previous report (Jo et al. 2007 ) and there were no differences among donors. The details on FACS analysis were described in our previous report (Chijimatsu et al. 2017 ).
Chondrogenesis assays
To perform two-dimension micromass culture (Decker et al. 2014) , hSMSCs harvested from passage 3 were suspended at a concentration of 1 9 10 7 cell/ mL in GM; 10 lL drops (1 9 10 5 cells) were spotted onto the center of the well of 24 well tissue culture plates (Corning, Corning, NY, USA) and cultured for 3 h at 37°C with humidified 5% CO 2 . Then, 0.5 mL of chondrogenic basal medium (Shirasawa et al. 2006 ) (high glucose-DMEM (Gibco), 110 lg/mL sodium pyruvate (Gibco), 1% ITS ? premix (Corning), 50 lg/mL ascorbic acid-2-phosphate (SigmaAldrich), 40 lg/mL L-proline (Wako, Osaka, Japan), 1% antibiotic-antimitotic) supplemented with or without 1 nM to 1 lM dexamethasone (Sigma-Aldrich, Cat# D4902), 50 ng/mL BMP2 (Medtronic, Dublin, Ireland), or 10 ng/mL TGFb3 (Peprotech, Rocky Hill, NJ, USA) were added. Cells were maintained at 37°C with humidified 5% CO 2 . DMSO (1 lL/mL; SigmaAldrich) served as the vehicle control. Alcian Blue staining (pH 1.0) and Oil Red O staining were performed at day 7 .
For three-dimension pellet culture, 2 9 10 5 cells harvested from passage 4 were centrifuged in 96 deep well polypropylene plates (Evergreen Scientific, Vernon, CA, USA) and cultured in GM. The next day, the medium was changed to chondrogenic medium supplemented with the same factors used for the twodimension micromass culture. The pellets were maintained with 0.5 mL medium at 37°C with humidified 5% CO 2 . The medium was replaced twice weekly.
The sulfated glycosaminoglycan (sGAG) in the pellets was measured by using Blyscan Glycosaminoglycan Assay Kit (Biocolor, Westbury, NY, USA) after lysis with papain. The cellularity was measured based on the double strand DNA (dsDNA) content using Qubit Ò 3.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) and Qubit TM dsDNA HS Assay kit (Thermo Fisher Scientific).
Histology and immunohistochemistry
The samples were fixed in 4% paraformaldehyde, embedded in paraffin wax, and the 5 lm sections were used for Safranin-O/fast green staining (Safranin-O) or immunostaining. Stains were performed as previously described (Chijimatsu et al. 2017; Shirasawa et al. 2006 ). The following antibodies were used: anticollagen type 2 (Kyowa Pharma Chemical, Toyama, Japan, Cat# F-57, 1:500 dilution) and anti-perilipin (CST, Danvers, MA, USA, Cat# 3470, 1:100 dilution). Type 2 collagen staining was automatically measured by Aperio Image Scope (Leica Biosystems, Wetzlar, Germany), and cells positive for perilipin were manually counted.
RNA and qRT-PCR
Total RNA was extracted with a Direct-Zol TM RNA kit (Zymo Research, Irvine, CA, USA) and reverse transcribed into complementary DNA using RevaTra Ace Ò qPCR RT Master Mix (TOYOBO, Osaka, Japan) according to the manufacturer's protocol. Quantitative RT-PCR was performed as previously described (Chijimatsu et al. 2017) . Target gene transcriptional levels were normalized to the level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression. The expression levels of each target gene was calculated by using the 2 -DCt method (Chijimatsu et al. 2017) . The Taqman assays used are as follows: PPARc, Hs00234592_m1; LPL, Hs00173425_m1; FABP4, Hs01086177_m1, Adiponectin, Hs00977214_m1; and GAPDH, Hs02758991_g1.
Results
Effect of dexamethasone on two-dimension chondrogenic culture of hSMSCs Initially, to clarify the effect of dexamethasone on chondrogenesis of hSMSCs, two-dimension micromass aggregates were cultured with various concentrations of dexamethasone (1 nM to 1 lM) in chondrogenic medium supplemented with or without BMP2 (50 ng/mL) and TGFb3 (10 ng/mL) for 7 days. Unexpectedly, adipocyte-like oil droplets were recognized in microscopic observation when the cell aggregates were treated with 100 nM dexamethasone alone. Moreover, similar droplets emerged even at 10 nM dexamethasone in the presence of BMP2 (Fig. 1a) . Based on this phenomenon, combined staining with Alcian Blue and Oil Red O was performed to assess chondrogenesis and adipogenesis ). In the absence of growth factors, 10 nM dexamethasone induced nodule formation stained with Alcian blue which implied the origin of chondrogenesis (Oh and Chun 2003) ; however, Oil Red O positive droplets which implied adipogenesis, were also detected in these nodules. When dexamethasone was used at concentrations over 100 nM, nodule formation and Alcian blue staining faded, while an increase in oil droplets was detected (Fig. 1b) . When combined with BMP2, nodule formation was induced at 10 nM dexamethasone, but a larger number of oil droplets was detected compared to that observed when dexamethasone was used alone. Notably, BMP2 sometimes induced adipogenesis without dexamethasone (Fig. 1c) . On the other hands, TGFb3 treatment thickened the micromass as a whole and strong Alcian blue staining was detected consist with previous report (De Bari et al. 2001; Park et al. 2005) . However, combination with dexamethasone decreased this effect in a dose dependent manner, and few oil droplets were sometimes observed when dexamethasone concentration was beyond 100 nM (Fig. 1d) . mRNA levels (Fig. 1e ) of adipocyte and adipogenesis-associated genes (PPARc, LPL, FABP4, and adiponectin) were significantly upregulated after dexamethasone treatment, and that was potentiated by BMP2. Consistent with the staining results, TGFb3 suppressed the induction of adipocyte-and adipogenesis-associated genes by dexamethasone in hSMSCs.
The effect of dexamethasone on chondrogenesis of hSMSCs depends on the dose and combined factors in three-dimension chondrogenic culture
To assess the effect of dexamethasone on cartilaginous tissue formation from hSMSCs, three-dimension pellet culture was conducted with various concentrations of dexamethasone (1 nM to 100 nM) in the presence of TGFb3 (10 ng/mL) or BMP2 (50 ng/mL). Without such chondrogenic factors, cartilaginous tissue formation failed as indicated by the lack of safranin-O staining (data not shown). When cultured with TGFb3 for 4 weeks, less than 10 nM dexamethasone enhanced the synthesis of proteoglycan stained with safranin-O compared to in those slight staining of vehicle control (Figs. 2a and S1 ). Although, type 2 collagen was clearly detected in only one donor, it was increased by addition of dexamethasone (Figs. 2a and S1 ). However, 100 nM dexamethasone disturbed cartilaginous tissue formation, and remarkably, a cavity-like space was observed in the pellet center (Fig. 2a, black  arrow ). There were less matrices in the area, but cells existed with elongated shape, unlike chondrocytes.
When cultured with BMP2 for 4 weeks, proteoglycan and type 2 collagen expression with many chondrocyte-like lacunas were observed only when less than 1 nM dexamethasone was used (Figs. 2a-c  and S1 ). However, such BMP2-induced cartilaginous tissue formation was drastically disturbed when more than 10 nM dexamethasone was used. Notably, many adipocyte-like cells were detected in these pellets (Figs. 2b, arrow heads and S1) consistent with the micromass culture results (Fig. 1c) . Since BMP2 is often used at a high dose over 200 ng/mL for chondrogenic induction of MSCs Hunziker 2007, 2011; Shirasawa et al. 2006; Yasui et al. 2016) , we additionally examined the combination of 250 ng/mL BMP2 and dexamethasone. Similarly, chondrogenesis was disturbed over 10 nM dexamethasone supplementation (data not shown). Fig. 1 Effect of dexamethasone on twodimension micromass chondrogenic culture of hSMSCs. Representative data from three independent donors are shown. a The microscopic image of twodimensional micromass culture in 100 nM dexamethasone or BMP2 ? 10 nM dexamethasone on day 7. Arrows indicate the presence of oil droplets. Scale bars = 100 lm (left panels) and 20 lm (right panels). b-d Bright field images of Alcian blue and Oil Red O staining of micromass cultured with various concentrations of dexamethasone (1-1000 nM) with or without TGF#3 (10 ng/mL) and BMP2 (50 ng/mL) on day 7. Blue color indicates glycosaminoglycan deposition and red color indicates oil droplets of cytoplasm. Scale bars = 1 mm (upper panels) and 100 lm (lower panels). e Quantitative mRNA expression analysis of adipogenic genes (PPARc, FABP4, LPL, and Adiponectin) in the micromass cultured with dexamethasone (0, 10, 100 nM) with or without TGFb3 (10 ng/mL) and BMP2 (50 ng/mL) at day 7 (mean ± SD for three micromass). ND not detected. (Color figure online) Consistent with histological assessment, the sulfated GAG content of pellets decreased in the presence of high doses of dexamethasone, but the dsDNA content was not altered, suggesting that dexamethasone did not affect chondrogenesis by influencing cell viability (Fig. 2d) .
High dexamethasone dose causes adipogenesis dominant in chondrogenic culture of hSMSCs
To detect adipocytes in paraffin embedded samples, perilipin, which forms the membrane of oil droplets, was detected by immunostaining. As shown in Fig. 3a, perilipin positive adipocytes were detected in the whole pellets cultured with BMP2 and 10-100 nM dexamethasone, and increased dependent on the dose of dexamethasone. Of note, although 1 nM dexamethasone did not disturb BMP2-induced chondrogenesis, few adipocytes were detected in the formed cartilaginous tissues in all three donors (Fig. 3b) . Furthermore, perilipin positive cells were detected when hSMSCs were cultured with TGFb3 and 100 nM dexamethasone, and the location was biased in the cavity-like area, implying a relationship between adipogenesis and cavity-like tissue formation. In the condition of TGFb3 and less than 10 nM Fig. 2 Differential effect of dexamethasone on three-dimension chondrogenic culture of hSMSCs dependent on the dose and combined factors. The data of donor 2 from three independent donors are shown as representative results. The data obtained from the other two donors are shown in supplementary data. a, b Safranin-O staining and immunostaining for type 2 collagen of the pellets cultured with dexamethasone (0, 1, 10, 100 nM) and TGFb3 (10 ng/mL) or BMP2 (50 ng/mL) for 28 days. The area of the periphery and center of Safranin-O staining and featured area of COL2 staining were magnified in the lower panels. Scale bars = 500 lm (whole pellet images) and 100 lm (magnified images). Arrows indicate the cavity-like area shown in only the condition of 100 nM dexamethasone and TGFb3. Arrow heads indicate adipocyte-like oil droplets. c Quantitative area analysis of immunostaining for type 2 collagen (mean ± SD for three pellets). d The content of sulfated GAG and double-strand DNA of chondrogenic pellets on day 28 (mean ± SD for three pellets). (Color figure online) dexamethasone, perilipin positive cells were not detected in all three donors (Fig. 3b) .
Dexamethasone causes adipocyte contamination of tissue engineered cartilage
The combination of TGFb3 and BMP2 is considered an optimal condition to induce chondrogenesis of hSMSCs (Shirasawa et al. 2006) . Consistently, the combination of TGFb3 and BMP2 effectively induced the formation of cartilaginous tissues, which were rich in proteoglycan and type 2 collagen compared with those cultured with only TGFb3 or BMP2 (Figs. 4a  and S2 ). Dexamethasone further promoted cartilaginous tissue formation as assessed by weight, sulfated GAG content, and homogenous organization of type 2 collagen ( Fig. 4b-d) . Although, 100 nM dexamethasone increased tissue volume without sensitively influencing the sulfated GAG content, formed tissues were often heterogeneous with a fibrotic center (donor 1: N = 3/3, donor 2: N = 2/3, donor 3: N = 0/3), similar to that observed in the combination of TGFb3 and 100 nM dexamethasone. Furthermore, perilipinpositive cells were also detected in all tissues obtained from all donors only with 100 nM dexamethasone supplementation. They were mainly detected in the fibrotic area, but few adipocytes were observed in the area rich in proteoglycan and type 2 collagen (Figs. 4e, black arrow heads, f and S2).
Discussion
Dexamethasone is one of the major glucocorticoids used to induce chondrogenesis. In the present study, we investigated the optimal concentration of dexamethasone on chondrogenic induction and engineering of cartilaginous tissue from hSMSCs combined with TGFb3 and/or BMP2. Although the supplementation of dexamethasone showed the best results in term of cartilaginous tissue generation, it also induced adipogenesis when used at 100 nM, the generally used dose, revealing issues in engineering cartilage using hSMSCs.
Previous reports demonstrated that dexamethasone affects human bone marrow and synovial derived stem cells via glucocorticoid receptor (GR) (Derfoul et al. 2006; Florine et al. 2013; Gossye et al. 2009 ), and activated GR signaling has been known to upregulate C/EBPs, leading to the expression of PPARc, the master regulator of adipogenesis (Cristancho and Lazar 2011; Rosen and MacDougald 2006) . Furthermore, BMP2 has also been known to potentiate adipogenesis of MSCs in adipogenic conditions when PPARc is upregulated (Sottile and Seuwen 2000; Takada et al. 2012) . As shown in Fig. S3 , the combination of BMP2 with other glucocorticoids (prednisolone, betamethasone, and fluocinolone acetonide) also showed enhanced adipogenesis of hSMSCs. Collectively, glucocorticoids may trigger adipogenic differentiation of hSMSCs via GR signaling and may be strongly dominated by BMP2 stimulation, following interruption of chondrogenic differentiation.
Our data further demonstrated that the dose of dexamethasone sensitively affects the chondrogenesis in combination with not only BMP2, but also TGFb3. It has been reported that dexamethasone promotes chondrogenesis of MSCs via enhancing TGFbsinduced phosphorylation of SMADs (Hara et al. 2015) , and TGFbs inhibit adipogenesis of MSCs via blockade of C/EBPs expression (Cristancho and Lazar 2011; Rosen and MacDougald 2006) . Consistently, TGFb3 treatment suppressed dexamethasone-induced adipogenesis of hSMSCs and improved cartilaginous tissue formation when dexamethasone concentration was no more than 10 nM. Although dexamethasone is typically used at a concentration of 100 nM for chondrogenic induction of many types of MSCs (Derfoul et al. 2006; Diekman et al. 2010; Fellows et al. 2016; Florine et al. 2013; Johnstone et al. 1998; Park et al. 2005; Randau et al. 2013) , the effect was opposite in hSMSCs. Consistent with our results, heterogeneous tissue formation with cavity-like center was also observed in previous hSMSCs studies (Kim et al. 2011; Lee et al. 2009; Pei et al. 2008; Shirasawa et al. 2006 ), but the relationship with adipogenesis has not been mentioned. hSMSCs have high differentiation potential for adipogenesis as well as chondrogenesis (Mochizuki et al. 2006; Sakaguchi et al. 2005) , and our results indicated that such two cell fates were competitive in the supplementation between dexamethasone and TGFb3. Therefore, use of adipogenic inhibitors or increasing TGFb3 dose may further improve chondrogenic differentiation and cartilaginous tissue formation.
Recently, fluocinolone acetonide, a glucocorticoid, was reported as a strong inducer of TGFb3-associated chondrogenesis of bone marrow MSCs via effective enhancement of GR signaling when compared to dexamethasone (Hara et al. 2015) . However, as shown in this study, GR signaling does not always act in favor of chondrogenesis, instead it needs to be adequately restricted for chondrogenic induction of hSMSCs. GR signaling is not only modulated by type and dose of glucocorticoids (Hara et al. 2015; Mushtaq et al. 2002) , but also by intracellular environment. GR has two isoforms, and one of which is known to negatively regulate GR signaling (Chatzopoulou et al. 2015) . Therefore, ratio of those expressions is closely involved in the sensitivity to glucocorticoids, that depends on type and state of cells (John et al. 2016) . Thus, GR signaling should be carefully examined for specific cells when using a specific glucocorticoid as it may be important to regulate the differentiation of stem cells towards a specific lineage.
There are several limitations in this study. We examined hSMSCs from only three donors which may be insufficient to generalize the protocol for cartilaginous tissue formation. Moreover, intercellular mechanisms how GR signaling enhances or inhibits chondrogenesis on the interactions among PPARc, SMADs, and other signalings was difficult to investigate in this study. Furthermore, we have to clarify the influence of such adipocytes contamination on clinical output of transplantation therapy.
In conclusion, the optimal conditions to efficiently induce chondrogenesis and cartilaginous tissue formation from hSMSCs may be combination of 10 nM dexamethasone with TGFb3 and BMP2. Our study further suggests that optimizing GR signaling may be of importance for in vitro engineering of cartilage from MSCs.
